Black Titan (BTTC)
NASDAQ:BTTC
Top Page
No summary available
Positive Factors
Cash Flow Improvement
Improvement in free cash flow, although slight, indicates progress towards better cash management, which is crucial for sustaining operations and reducing reliance on external financing.
Negative Factors
Operational Inefficiencies
Operational inefficiencies leading to net losses reflect high expenses relative to revenue, posing a significant barrier to achieving sustainable profitability and growth.
Read all positive and negative factors
Positive Factors
Negative Factors
Cash Flow Improvement
Improvement in free cash flow, although slight, indicates progress towards better cash management, which is crucial for sustaining operations and reducing reliance on external financing.
Read all positive factors
Black Titan (BTTC) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$12.90M
Dividend YieldN/A
Average Volume (3M)508.16K
Price to Earnings (P/E)―
Beta (1Y)0.53
Revenue GrowthN/A
EPS Growth60.78%
CountryUS
Employees37
SectorGeneral
Sector StrengthN/A
IndustryAsset Management
Share Statistics
EPS (TTM)N/A
Shares Outstanding9,086,610
10 Day Avg. Volume493,518
30 Day Avg. Volume508,156
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap59.10
Enterprise Value/Revenue284.21
Enterprise Value/Gross Profit861.74
Enterprise Value/Ebitda-1.51K
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Black Titan Business Overview & Revenue Model
Company Description
Black Titan Corp. was formed for the purpose of effecting a merger between Titan Pharmaceuticals Inc. and TalenTec Sdn Bhd. It intends to explore and identify viable business opportunities. The company was founded on July 11, 2024 and is headquart...
How the Company Makes Money
Titan Pharmaceuticals generates revenue primarily through the commercialization of its flagship product, Probuphine. The company earns income from product sales, licensing agreements, and royalties. Probuphine, as a treatment for opioid dependence...
Black Titan Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | TTM | Jul 2025 | Jul 2024 | Jul 2023 | Jul 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.68M | 2.68M | 2.12M | 2.08M | 2.40M | 1.53M |
| Gross Profit | 884.93K | 884.93K | 686.84K | 464.11K | 550.46K | 1.22M |
| EBITDA | -503.44K | 286.56K | 237.23K | 107.34K | 27.11K | -8.55M |
| Net Income | -580.09K | 209.91K | 153.23K | 11.69K | -86.56K | -8.78M |
Balance Sheet | ||||||
| Total Assets | 23.23B | 2.72M | 2.22M | 1.10M | 1.34M | 7.99M |
| Cash, Cash Equivalents and Short-Term Investments | 74.09M | 575.11K | 371.96K | 3.35K | 6.96K | 6.33M |
| Total Debt | 825.70M | 302.15K | 294.14K | 669.51K | 836.09K | 299.00K |
| Total Liabilities | 3.34B | 1.77M | 1.21M | 1.34M | 1.60M | 2.86M |
| Stockholders Equity | 19.89B | 954.29K | 1.00M | -242.48K | -255.13K | 5.14M |
Cash Flow | ||||||
| Free Cash Flow | -235.21K | 270.79K | 190.03K | 308.48K | -411.00 | -7.92M |
| Operating Cash Flow | -111.78K | 394.22K | 191.55K | 308.48K | -252.00 | -7.90M |
| Investing Cash Flow | -123.42K | -123.42K | -1.53K | 0.00 | -159.00 | -23.00K |
| Financing Cash Flow | -479.20K | -417.20K | 556.46K | -302.84K | -25.63K | 8.84M |
Black Titan Technical Analysis
Positive
1.69
Price Trends
1.52
Negative
1.98
Negative
3.37
Negative
Market Momentum
-0.05
Negative
50.84
Neutral
17.08
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For BTTC, the sentiment is Positive. The current price of 1.69 is above the 20-day moving average (MA) of 1.35, above the 50-day MA of 1.52, and below the 200-day MA of 3.37, indicating a neutral trend. The MACD of -0.05 indicates Negative momentum. The RSI at 50.84 is Neutral, neither overbought nor oversold. The STOCH value of 17.08 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BTTC.
Black Titan Risk Analysis
Black Titan disclosed 29 risk factors in its most recent earnings report. Black Titan reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Black Titan Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
| ― | $12.90M | >-0.01 | -109.09% | ― | ― | 60.78% | |
51 Neutral | $29.42M | 71.21 | 39.00% | ― | -37.08% | ― | |
51 Neutral | $6.84M | -1.17 | -25.88% | 1.07% | 66.65% | -1497.99% | |
45 Neutral | $7.34M | -0.16 | -1438.14% | ― | -62.09% | -99.89% | |
42 Neutral | $57.99M | ― | 38.19% | ― | -33.98% | 94.83% | |
41 Neutral | $7.25M | -0.33 | -925.11% | ― | ― | ― |
* General Sector Average
BTTC
Black Titan
1.42
-2.33
-62.13%
ATON
AlphaTON Capital
0.31
-8.57
-96.52%
BCG
Binah Capital Group
1.76
-0.45
-20.36%
BENF
Beneficient
4.08
1.68
70.00%
CWD
CaliberCos, Inc. Class A
1.04
-9.82
-90.42%
MLCI
Mount Logan Capital Inc
3.77
-4.14
-52.33%
Black Titan Corporate Events
Black Titan Appoints New Co-CEO Amid Strategic Expansion
Nov 14, 2025
On November 10, 2025, Black Titan Corporation appointed Czhang Lin as Co-Chief Executive Officer, enhancing its leadership team to drive strategic expansion into the digital asset and blockchain sectors. Mr. Lin, with extensive experience in crypt...
Black Titan Completes Major Acquisition and Secures $5.5 Million Investment
Oct 9, 2025
On October 1, 2025, Black Titan Corporation completed a significant business combination by acquiring Titan Pharmaceuticals and TalenTec, making them wholly owned subsidiaries. This strategic move, approved by Titan’s stockholders on August ...
Black Titan Corporation Announces Strategic Crypto Initiatives
Oct 7, 2025
On October 6, 2025, Black Titan Corporation announced its intention to explore long-term strategic initiatives in the cryptocurrency sector. The company aims to leverage debt, equity, and cash flow to build its crypto holdings, capitalizing on eme...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―